In relationship with SNVs resulting from somatic changes in AD, there are two recent studies reporting the presence of low allele frequency mosaic mutations in the brain of AD patients, both of them focused to scrutinize SNVs at the APP, PSEN1, PSEN2 and MAPT loci17, 18. This evidence concerns the gene PSEN2 and Alzheimer disease.